Heightened plasma levels of heme oxygenase-1 and tissue inhibitor of metalloproteinase-4 as well as elevated peripheral neutrophil counts are associated with TB-diabetes comorbidity

Chest

Volumn 145, Issue 6, 2014, Pages 1244-1254

  Andrade, Bruno B ^a   Pavan Kumar, Nathella ^a,b   Sridhar, Rathinam ^c   Banurekha, Vaithilingam V ^b   Jawahar, Mohideen S ^b   Nutman, Thomas B ^a   Sher, Alan ^a   Babu, Subash ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^c Government Stanley Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEME OXYGENASE 1; LOW DENSITY LIPOPROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ADULT; AGED; ARTICLE; BACTERIAL LOAD; CLINICAL ASSESSMENT; COMORBIDITY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INDIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL COUNT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPUTUM ANALYSIS;

ACUTE-PHASE PROTEINS; ADULT; AGED; BIOLOGICAL MARKERS; CELL COUNT; CHEMOKINES; COMORBIDITY; CROSS-SECTIONAL STUDIES; CYTOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; HEME OXYGENASE-1; HUMANS; INDIA; MALE; MIDDLE AGED; NEUTROPHILS; PREVALENCE; TISSUE INHIBITOR OF METALLOPROTEINASES; TUBERCULOSIS;

EID: 84901847967     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-1799     Document Type: Article

References (31)

1. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5 (7) : e152.
2. Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009;9 (12) : 737-746.
3. Baker MA, Harries AD, Jeon CY, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011;9:81.
4. Vallerskog T, Martens GW, Kornfeld H . Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis . J Immunol . 2010;184 (11) : 6275-6282 .
5. . Restrepo BI, Fisher-Hoch SP, Pino PA, et al . Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells . Clin Infect Dis . 2008;47 (5) : 634-641 .
6. . Kumar NP, Sridhar R, Banurekha VV, Jawahar MS, Nutman TB, Babu S . Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 dia betes mellitus . J Infect Dis . 2013;208 (5) : 739-748 .
7. . Tenhunen R, Marver HS, Schmid R . The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase . Proc Natl Acad Sci U S A. 1968;61 (2) : 748-755 .
8. Andrade BB, Pavan Kumar N, Mayer-Barber KD, et al. Plasma heme oxygenase-1 levels distinguish latent or successfully treated human tuberculosis from active disease. PLoS ONE. 2013;8 (5) : e62618.
9. Pavan Kumar N, Anuradha R, Andrade BB, et al. Circulating biomarkers of pulmonary and extrapulmonary tuberculosis in children. Clin Vaccine Immunol. 2013;20 (5) : 704-711.
10. Bao W, Rong S, Zhang M, et al. Plasma heme oxygenase-1 concentration in relation to impaired glucose regulation in a non-diabetic Chinese population. PLoS ONE. 2012;7 (3) : e32223.
11. de Beer FC, Nel AE, Gie RP, Donald PR, Strachan AF. Serum amyloid A protein and C-reactive protein levels in pulmonary tuberculosis: relationship to amyloidosis. Thorax. 1984;39 (3) : 196-200. (Pubitemid 14154226)
12. Elkington P, Shiomi T, Breen R, et al. MMP-1 drives immunopathology in human tuberculosis and transgenic mice. J Clin Invest. 2011;121 (5) : 1827-1833.
13. Ugarte-Gil CA, Elkington P, Gilman RH, et al. Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis. PLoS ONE. 2013;8 (4) : e61333.
14. Deepa M, Pradeepa R, Rema M, et al. The Chennai Urban Rural Epidemiology Study (CURES) - study design and methodology (urban component) (CURES-I). J Assoc Physicians India. 2003;51:863-870. (Pubitemid 41279865)
15. Wallis RS, Kim P, Cole S, et al. Tuberculosis biomarkers discovery: developments, needs, and challenges. Lancet Infect Dis. 2013;13 (4) : 362-372.
16. Reed GW, Choi H, Lee SY, et al. Impact of diabetes and smoking on mortality in tuberculosis. PLoS ONE. 2013;8 (2) : e58044.
17. Choi SW, Yeung VT, Benzie IF. Heme oxygenase microsatellite polymorphism, oxidative stress, glycemic control, and complication development in type 2 diabetes patients. Free Radic Biol Med. 2012;53 (1) : 60-63.
18. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107 (9) : 1058-1070.
19. Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A. Immunological biomarkers of tuberculosis. Nat Rev Immunol. 2011;11 (5) : 343-354.
20. Wilson D, Badri M, Maartens G. Performance of serum C-reactive protein as a screening test for smear-negative tuberculosis in an ambulatory high HIV prevalence population. PLoS ONE. 2011;6 (1) : e15248.
21. Sundararajan S, Babu S, Das SD. Comparison of localized versus systemic levels of Matrix metalloproteinases (MMPs), its tissue inhibitors (TIMPs) and cytokines in tuberculous and non-tuberculous pleuritis patients. Hum Immunol. 2012;73 (10) : 985-991.
22. Elkington PT, Ugarte-Gil CA, Friedland JS. Matrix metalloproteinases in tuberculosis. Eur Respir J. 2011;38 (2) : 456-464.
23. Hsieh HL, Lin CC, Hsiao LD, Yang CM. High glucose induces reactive oxygen species-dependent matrix metalloproteinase-9 expression and cell migration in brain astrocytes. Mol Neurobiol. 2013;48 (3) : 601-614.
24. Li Z, Guo S, Yao F, Zhang Y, Li T. Increased ratio of serum matrix metalloproteinase-9 against TIMP-1 predicts poor wound healing in diabetic foot ulcers. J Diabetes Complications. 2013; 27 (4) : 380-382.
25. Han X, Sun Y, Scott S, Bleich D. Tissue inhibitor of metal-loproteinase-1 prevents cytokine-mediated dysfunction and cytotoxicity in pancreatic islets and beta-cells. Diabetes. 2001; 50 (5) : 1047-1055. (Pubitemid 32374535)
26. Federici M, Hribal ML, Menghini R, et al. Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha. J Clin Invest. 2005;115 (12) : 3494-3505. (Pubitemid 43121837)
27. Jung HY, Kim YG, Park JW, Suh JY, Lee JM. The expression of a nitric oxide derivative, tissue inhibitors of metalloproteinase-3, and tissue inhibitors of metalloproteinase-4 in chronic periodontitis with type 2 diabetes mellitus. J Periodontal Implant Sci. 2013;43 (2) : 87-95.
28. Lowe DM, Redford PS, Wilkinson RJ, O'Garra A, Martineau AR. Neutrophils in tuberculosis: friend or foe? Trends Immunol. 2012;33 (1) : 14-25.
29. Eruslanov EB, Lyadova IV, Kondratieva TK, et al. Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. Infect Immun. 2005; 73 (3) : 1744-1753. (Pubitemid 40470763)
30. Nandi B, Behar SM. Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection. J Exp Med. 2011;208 (11) : 2251-2262.
31. Berry MP, Graham CM, McNab FW, et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature. 2010;466 (7309) : 973-977.